SQSTM1 and renal cell carcinoma: To validate our findings that Sunitinib treatment decreases the PD‐L1 level through the p62‐mediated selective autophagy, we analyzed the p62 and PD‐L1 level by immunofluorescence staining in RCC patient samples before or after Sunitinib treatment.